Tag: Respiratory Problems: Misc.
FDA Approves Pfizer RSV Vaccine for Older Adults
CDC expected to meet later in the month to adopt vaccine recommendations for older Americans
Huge Mass of Sargassum Seaweed Is Targeting Florida’s Coast, With Hazards to Health
When decomposing, sargassum can release ammonia and hydrogen sulfide, which is toxic
Lung Transplants From COVID-19-Positive Donors May Be Feasible
Data from 47 carefully selected transplants show early posttransplant outcomes are similar to those seen with COVID-19-negative donors
Global Burden of Chronic Respiratory Diseases Quantified
Chronic respiratory diseases were third leading cause of death, accounting for 4.0 million deaths and prevalence of 454.6 million cases in 2019
FDA Panel Recommends Approval of First RSV Vaccine Given in Pregnancy to Protect Infants
The proposal next will go before the FDA; approval could take months
Current Surge Noted in RSV Infection, Especially in Older Children
Greater proportion of children hospitalized in 2022 to 2023 were aged 2 to younger than 5 years and aged 5 to younger than 12 years
RSV in First Year of Life Tied to Risk for Childhood Asthma
Authors say association is age- and severity-dependent
GERD Increases Risk for Idiopathic Pulmonary Fibrosis
However, Mendelian randomization study did not identify reverse effect
FDA Approves First RSV Vaccine
Arexvy was ~82 percent effective in preventing RSV-induced lower respiratory tract infections in adults 60 years of age and older
Disparities Seen in Patient Selection for Extracorporeal Membrane Oxygenation
ECMO use less likely among women, patients with Medicaid, and patients living in the lowest-income neighborhoods
